DekaBank Deutsche Girozentrale Takes Position in PetIQ, Inc. (NASDAQ:PETQ)

DekaBank Deutsche Girozentrale bought a new stake in PetIQ, Inc. (NASDAQ:PETQ) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,517 shares of the company’s stock, valued at approximately $50,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in PETQ. Captrust Financial Advisors boosted its position in shares of PetIQ by 1,149.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,562 shares of the company’s stock worth $26,000 after purchasing an additional 1,437 shares during the last quarter. Eagle Bay Advisors LLC boosted its position in shares of PetIQ by 142.9% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,683 shares of the company’s stock worth $28,000 after purchasing an additional 990 shares during the last quarter. FinTrust Capital Advisors LLC bought a new position in shares of PetIQ in the 3rd quarter worth $34,000. Quarry LP boosted its position in shares of PetIQ by 29.6% in the 2nd quarter. Quarry LP now owns 2,816 shares of the company’s stock worth $43,000 after purchasing an additional 643 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of PetIQ by 351.4% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 3,372 shares of the company’s stock worth $67,000 after purchasing an additional 2,625 shares during the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

PetIQ Stock Performance

PETQ stock opened at $15.93 on Thursday. The business’s 50-day moving average price is $17.52 and its two-hundred day moving average price is $18.44. The company has a current ratio of 2.27, a quick ratio of 1.43 and a debt-to-equity ratio of 1.97. The firm has a market cap of $468.82 million, a PE ratio of 265.54 and a beta of 1.64. PetIQ, Inc. has a 1-year low of $10.98 and a 1-year high of $22.98.

PetIQ (NASDAQ:PETQ) last posted its earnings results on Wednesday, February 28th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.22. The firm had revenue of $219.93 million for the quarter, compared to analyst estimates of $189.70 million. PetIQ had a return on equity of 11.72% and a net margin of 0.19%. As a group, research analysts forecast that PetIQ, Inc. will post 0.94 earnings per share for the current year.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised their price target on PetIQ from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Tuesday, March 19th. Four equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $29.00.

About PetIQ

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.